Response by Bonde and Martinussen to Letter Regarding Article, "Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation: An Instrumental Variable Analysis of a Nationwide Cohort"

Affiliations

¹ Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark (A.N.B.).
² Department of Public Health, Section of Biostatistics, University of Copenhagen, Denmark (T.M.).

Comment

Anders Nissen Bonde et al. Circ Cardiovasc Qual Outcomes. 2020 Aug.

. 2020 Aug;13(8):e007003.

doi: 10.1161/CIRCOUTCOMES.120.007003. Epub 2020 Aug 19.

¹ Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark (A.N.B.).
² Department of Public Health, Section of Biostatistics, University of Copenhagen, Denmark (T.M.).

No abstract available

Comment on

Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation: An Instrumental Variable Analysis of a Nationwide Cohort.
Bonde AN, Martinussen T, Lee CJ, Lip GYH, Staerk L, Bang CN, Bhattacharya J, Gislason G, Torp-Pedersen C, Olesen JB, Hlatky MA. Bonde AN, et al. Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006058. doi: 10.1161/CIRCOUTCOMES.119.006058. Epub 2020 Apr 14. Circ Cardiovasc Qual Outcomes. 2020. PMID: 32283966
Letter by Nielsen and Søgaard Regarding Article, "Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation: An Instrumental Variable Analysis of a Nationwide Cohort".
Brønnum Nielsen P, Søgaard M. Brønnum Nielsen P, et al. Circ Cardiovasc Qual Outcomes. 2020 Aug;13(8):e006889. doi: 10.1161/CIRCOUTCOMES.120.006889. Epub 2020 Aug 19. Circ Cardiovasc Qual Outcomes. 2020. PMID: 32813565 No abstract available.